Welcome to the BADBIR database

You have been automatically logged out. If you were still working on a database page prior to log out there is a possibility this data was not saved. Please log in again.

Welcome to the BADBIR Database

1/6 Visit us at the BDNG Annual Conference 2025 in Harrogate!
2/6 Recruitment to Taltz has ended
3/6 Read more: Changes to conventional cohort eligibility criteria
4/6 Our new 2025 Annual Update is available to read here
5/6 Patients diagnosed with Generalised Pustular Psoriasis are eligible on Spevigo (spesolimab) or conventional treatment
6/6 Reminder that we currently recruit for patients on Sotyktu (deucravacitinib)